Tripartite Therapeutics Inc. Stock Price

TPEX:7920 Community·NT$8.2b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

7920 Share Price Performance

NT$13.85

6.77 (95.62%)

NT$13.85

6.77 (95.62%)

NT$13.85

Fri, 26 Jun 26

Share Pricen/a

7920 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks

0 Rewards

View Full Analysis

Tripartite Therapeutics Inc. Key Details

Last Reported Earnings

n/a

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About 7920

Founded: 2009
Employees: n/a
CEO: Anthony Lin
WebsiteView website: www.2t-pharma.com

Tripartite Therapeutics Inc. engages in the development of proprietary platform technologies for targeted delivery of therapeutics in Taiwan. Its proprietary OmniLink technology, helps in the therapeutic potential of active pharmaceutical ingredients that were previously limited by toxicities, in vivo stabilities, and unfavorable pharmacokinetic profiles. The company aims to generate a pipeline of treatments for cancer tumors, unmet medical needs in oncology, metabolic diseases, vaccines, and other disease indications. The company was founded in 2009 and is headquartered in Taipei, Taiwan.